Who invested in Esperas Pharma?
One investor is on record as having backed Esperas Pharma — Testing compound for triple-negative breast cancer, in Biotech. Each row below says whether the round came from the investor's own portfolio page or from the press.
Esperas Pharma investors
No round dates are on record for Esperas Pharma. A portfolio page names its companies far more often than it dates the cheque, and we would rather leave the field empty than guess it.
The funds that backed Esperas Pharma are in the directory.
If they wrote this cheque, they may write yours. Pitch2Fund scores your startup against every one of them, gives you the partner to write to, and drafts the email. Free.